Abstract:Abstract BACKGROUND AND AIMS Atherogenic index of plasma (AIP), a logarithmically transformed ratio of triglyceride (TG)/high-density lipoprotein cholesterol (HDL-C), is a biomarker of dyslipidemia and cardiovascular disease (CVD) risk. However, its applicability in end-stage kidney disease (ESKD) is not clear. We examined the association of AIP with all-cause and CVD mortality in two cohorts of ESKD patients, one from China and one from Sweden. METHOD In 1276 Chinese incident peritoneal dialysis (PD) patients (median age 50 years, 56% males) and 559 Swedish ESKD patients starting on dialysis (n = 392) or undergoing hemodialysis (n = 109) or PD 58 (median age 58 years, 62% males), baseline AIP and other biochemical and metabolic biomarkers were analysed in relation to mortality during follow-up period of up to 5 years. All-cause and CVD mortality risk were analysed with competing-risk regression models with transplantation as competing risk adjusting for age, sex, smoking, diabetes, serum albumin, hemoglobulin and calendar year. RESULTS Chinese patients [median (IQR) BMI 21 (19–23) kg/m2 TG 1.4 (1.0–1.8) and HDL-C 1.0 (0.9–1.3) mmol/L] compared with Swedish patients [median (IQR) BMI 24 (22–28)] kg/m2 TG 1.6 (1.2–2.2) and HDL-C 1.2 (1.0–1.6) mmol/L] were significantly younger (P < 0.01) and had lower BMI (P < 0.01), TG (P < 0.001), HDL-C (P < 0.001), and Framingham risk score (P < 0.01) while sex distribution was similar. ‘Chinese patients’: After median 3.6 years of follow-up, all-cause mortality rate was 16%, and 91 (46%) of the 199 deaths were caused by CVD. The highest tertile of AIP was associated with higher all-cause [sub-hazard ratio sHR (95% CI) 1.52 (1.05); Fig. 1A] and CVD mortality [sHR 1.82 (1.02–3.27); Fig. 1B] risk, after adjusting for confounders. ‘Swedish patients’: After median 2.1 years of follow-up, all-cause mortality rate was 36%, and 89 (44%) of the 204 deaths were caused by CVD. The highest tertile of AIP was associated with lower all-cause [sHR 0.66 (0.47–0.94); Fig. 2A] and CVD mortality [sHR 0.59 (0.35–0.97); Fig. 2B] risk after adjusting for confounders. CONCLUSION The highest tertile of AIP was independently associated with higher mortality risk in Chinese ESKD patients while it was associated with lower mortality risk in Swedish ESKD patients suggesting that AIP is context dependent, which limits is usefulness as a risk-assessment tool for predicting clinical outcomes in ESKD patients.

Association between cumulative atherogenic index of plasma exposure and risk of myocardial infarction in the general population

Elevated Atherogenic Index of Plasma Increased the Risk of Myocardial Infarction in a General Population.

Association Between Ideal Cardiovascular Health and the Atherogenic Index of Plasma

The predictive value of cumulative atherogenic index of plasma (AIP) for cardiovascular outcomes: a prospective community-based cohort study

Elevated atherogenic index of plasma associated with stroke risk in general Chinese

Association Between Atherogenic Index of Plasma and Risk of Incident Major Adverse Cardiovascular Events

Predictive value of atherogenic index of plasma and atherogenic index of plasma combined with low-density lipoprotein cholesterol for the risk of acute myocardial infarction

Association between the atherogenic index of plasma and adverse long-term prognosis in patients diagnosed with chronic coronary syndrome

Association between atherogenic index of plasma and all-cause mortality and specific-mortality: a nationwide population‑based cohort study

A U-shaped relationship between the atherogenic index of plasma and repeated target vessel revascularization in patients undergoing percutaneous coronary intervention: a retrospective study

The atherogenic index of plasma and carotid atherosclerosis in a community population: a population-based cohort study in China

MO708: Association of Atherogenic Index of Plasma (AIP) with Mortality in Chinese and Swedish End-Stage Kidney Disease Patients: Results from Two Cohorts

Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study

Association between the atherogenic index of plasma and abdominal aortic calcification in adults: a cross-sectional study

Peripheral Inflammatory Biomarkers For Myocardial Infarction Risk: A Prospective Community-Based Study

The atherogenic index of plasma (AIP) is a predictor for the severity of coronary artery disease

Atherogenic index of plasma: a new indicator for assessing the short-term mortality of patients with acute decompensated heart failure

Association Between the Aggregate Index of Systemic Inflammation and Clinical Outcomes in Patients with Acute Myocardial Infarction: A Retrospective Study

Atherogenic index of plasma for non-diabetic, coronary artery disease patients after percutaneous coronary intervention: a prospective study of the long-term outcomes in China

The Relationship Between Atherogenic Index of Plasma and Carotid Intima-Media Thickness in Patients with Cerebral Infarction

Atherogenic Index of Plasma Predicts Outcomes in Acute Ischemic Stroke